These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 18925455)
1. Identification of fibronectin type I domains as amyloid-binding modules on tissue-type plasminogen activator and three homologs. Maas C; Schiks B; Strangi RD; Hackeng TM; Bouma BN; Gebbink MF; Bouma B Amyloid; 2008 Sep; 15(3):166-80. PubMed ID: 18925455 [TBL] [Abstract][Full Text] [Related]
2. Spatial orientation of tissue-type plasminogen activator bound at the melanoma cell surface. Bizik J; Trancikova D; Felnerova D; Verheijen JH; Vaheri A Biochem Biophys Res Commun; 1997 Oct; 239(1):322-8. PubMed ID: 9345318 [TBL] [Abstract][Full Text] [Related]
3. Plasmin cleavage of the amyloid beta-protein: alteration of secondary structure and stimulation of tissue plasminogen activator activity. Van Nostrand WE; Porter M Biochemistry; 1999 Aug; 38(35):11570-6. PubMed ID: 10471309 [TBL] [Abstract][Full Text] [Related]
4. Tissue-type plasminogen activator binds to Aβ and AIAPP amyloid fibrils with multiple domains. Beringer DX; Fischer MJ; Meeldijk JD; van Donselaar EG; de Mol NJ; Kroon-Batenburg LM Amyloid; 2013 Jun; 20(2):113-21. PubMed ID: 23697555 [TBL] [Abstract][Full Text] [Related]
5. Ageing and amyloid-beta peptide deposition contribute to an impaired brain tissue plasminogen activator activity by different mechanisms. Cacquevel M; Launay S; Castel H; Benchenane K; Chéenne S; Buée L; Moons L; Delacourte A; Carmeliet P; Vivien D Neurobiol Dis; 2007 Aug; 27(2):164-73. PubMed ID: 17566751 [TBL] [Abstract][Full Text] [Related]
6. The effector roles of kringle 1 and kringle 2 in the enzymatic properties of recombinant tissue-type plasminogen activator as revealed by generation of recombinant molecules containing each kringle linked to the protease domain. Rydzewski A; Castellino FJ Arch Biochem Biophys; 1993 Jan; 300(1):472-82. PubMed ID: 8424682 [TBL] [Abstract][Full Text] [Related]
7. Identification of a putative binding site for negatively charged surfaces in the fibronectin type II domain of human factor XII--an immunochemical and homology modeling approach. Citarella F; te Velthuis H; Helmer-Citterich M; Hack CE Thromb Haemost; 2000 Dec; 84(6):1057-65. PubMed ID: 11154114 [TBL] [Abstract][Full Text] [Related]
9. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin. Doolittle RF; Pandi L Biochemistry; 2006 Feb; 45(8):2657-67. PubMed ID: 16489759 [TBL] [Abstract][Full Text] [Related]
10. The heparin III-binding domain of fibronectin (III4-5 repeats) binds to fibronectin and inhibits fibronectin matrix assembly. Maqueda A; Moyano JV; Hernández Del Cerro M; Peters DM; Garcia-Pardo A Matrix Biol; 2007 Oct; 26(8):642-51. PubMed ID: 17611093 [TBL] [Abstract][Full Text] [Related]
11. Lysine 156 promotes the anomalous proenzyme activity of tPA: X-ray crystal structure of single-chain human tPA. Renatus M; Engh RA; Stubbs MT; Huber R; Fischer S; Kohnert U; Bode W EMBO J; 1997 Aug; 16(16):4797-805. PubMed ID: 9305622 [TBL] [Abstract][Full Text] [Related]
12. Differential binding of factor XII and activated factor XII to soluble and immobilized fibronectin--localization of the Hep-1/Fib-1 binding site for activated factor XII. Schousboe I; Nystrøm BT; Hansen GH FEBS J; 2008 Oct; 275(20):5161-72. PubMed ID: 18793325 [TBL] [Abstract][Full Text] [Related]
13. The extracellular matrix proteins laminin and fibronectin contain binding domains for human plasminogen and tissue plasminogen activator. Moser TL; Enghild JJ; Pizzo SV; Stack MS J Biol Chem; 1993 Sep; 268(25):18917-23. PubMed ID: 8360181 [TBL] [Abstract][Full Text] [Related]
14. Physiological responses to protein aggregates: fibrinolysis, coagulation and inflammation (new roles for old factors). Gebbink MF; Bouma B; Maas C; Bouma BN FEBS Lett; 2009 Aug; 583(16):2691-9. PubMed ID: 19527723 [TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of human polyserase-3, a novel protein with tandem serine-protease domains in the same polypeptide chain. Cal S; Peinado JR; Llamazares M; Quesada V; Moncada-Pazos A; Garabaya C; López-Otín C BMC Biochem; 2006 Mar; 7():9. PubMed ID: 16566820 [TBL] [Abstract][Full Text] [Related]
17. Solution structure of the glycosylated second type 2 module of fibronectin. Sticht H; Pickford AR; Potts JR; Campbell ID J Mol Biol; 1998 Feb; 276(1):177-87. PubMed ID: 9514732 [TBL] [Abstract][Full Text] [Related]
18. Extended and flexible domain solution structure of the extracellular matrix protein anosmin-1 by X-ray scattering, analytical ultracentrifugation and constrained modelling. Hu Y; Sun Z; Eaton JT; Bouloux PM; Perkins SJ J Mol Biol; 2005 Jul; 350(3):553-70. PubMed ID: 15949815 [TBL] [Abstract][Full Text] [Related]
19. Activation of human platelets by misfolded proteins. Herczenik E; Bouma B; Korporaal SJ; Strangi R; Zeng Q; Gros P; Van Eck M; Van Berkel TJ; Gebbink MF; Akkerman JW Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1657-65. PubMed ID: 17510465 [TBL] [Abstract][Full Text] [Related]
20. The ShdA adhesin binds to the cationic cradle of the fibronectin 13FnIII repeat module: evidence for molecular mimicry of heparin binding. Kingsley RA; Keestra AM; de Zoete MR; Bäumler AJ Mol Microbiol; 2004 Apr; 52(2):345-55. PubMed ID: 15066025 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]